UCL Institute of Neurology
Research and teaching excellence
The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases. A number of important research centres are based at the Institute, including the MRC Centre for Neuromuscular Diseases and the Wellcome Centre for Human Neuroimaging
The hub of the research activities and operational headquarters of the UK Dementia Research Institute (DRI) are also at UCL, embedded within the Institute.
Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience.
The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.
What We Do
Please see our Infographic highlighting key data on the Institute.
Epilepsy is associated with thickness and volume differences in the grey matter of several brain regions, according to new research led by UCL Institute of Neurology and the Keck School of Medicine of USC.
Published: Jan 22, 2018 11:29:04 AM
We are delighted to announce that Professor Eleanor Maguire (Deputy
Director of the Wellcome Centre for Human Neuroimaging, UCL Institute of Neurology) has been elected an Honorary Member of the Royal Irish Academy, Ireland's leading body of experts in the Sciences and Humanities.
Published: Dec 18, 2017 2:05:03 PM
The UK Dementia Research Institute (UK DRI) have announced a £1.5 million award to fund research into Huntington’s disease which will be led by UCL Institute of Neurology researchers Professors Gillian Bates and Sarah Tabrizi. The programme will look to better understand the DNA damage that occurs as this neurodegenerative disease unfolds as well as the potential for better targets for treatment.
Published: Dec 18, 2017 1:33:40 PM